162 related articles for article (PubMed ID: 19852699)
21. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
[TBL] [Abstract][Full Text] [Related]
22. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
24. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
Kaufman ES; Zimmermann PA; Wang T; Dennish GW; Barrell PD; Chandler ML; Greene HL;
J Am Coll Cardiol; 2004 Sep; 44(6):1276-82. PubMed ID: 15364332
[TBL] [Abstract][Full Text] [Related]
25. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
26. Results of atrial fibrillation ablation during mitral surgery in patients with poor electro-anatomical substrate.
Onorati F; Rubino AS; Mariscalco G; Serraino F; Sala A; Renzulli A
J Heart Valve Dis; 2009 Nov; 18(6):607-16. PubMed ID: 20099709
[TBL] [Abstract][Full Text] [Related]
27. Hospital readmissions in US atrial fibrillation patients: occurrence and costs.
Amin AN; Jhaveri M; Lin J
Am J Ther; 2013; 20(2):143-50. PubMed ID: 23183097
[TBL] [Abstract][Full Text] [Related]
28. Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.
Suh DC; Nelson WW; Choi JC; Choi I
Clin Ther; 2012 Jul; 34(7):1569-82. PubMed ID: 22717419
[TBL] [Abstract][Full Text] [Related]
29. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany.
McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B
Value Health; 2009; 12(2):293-301. PubMed ID: 18657103
[TBL] [Abstract][Full Text] [Related]
30. Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry.
Amerena J; Chen SA; Sriratanasathavorn C; Cho JG; Huang D; Omar R; Tse HF; King A
Am J Cardiol; 2012 Feb; 109(3):378-82. PubMed ID: 22118827
[TBL] [Abstract][Full Text] [Related]
31. [Atrial fibrillation in 2010: an increasing morbidity and mortality burden].
Davy JM; Roubille F; Tri Cung T; Massin F; Crausac F; Raczka F; Pasquié JL
Ann Cardiol Angeiol (Paris); 2010 Dec; 59 Suppl 1():S4-13. PubMed ID: 21211625
[TBL] [Abstract][Full Text] [Related]
32. [Atrial fibrillation--epidemiologic, economic and individual burden of disease].
Brüggenjürgen B; Reinhold T; McBride D; Willich SN
Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S21-5. PubMed ID: 20221974
[TBL] [Abstract][Full Text] [Related]
33. Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United States.
Kim MH; Lin J; Kreilick C; Foltz Boklage SH
Adv Ther; 2010 Sep; 27(9):600-12. PubMed ID: 20700678
[TBL] [Abstract][Full Text] [Related]
34. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
Pinzón JF; Maldonado C; Díaz JA; Segura O
Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
[TBL] [Abstract][Full Text] [Related]
35. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.
Kim MH; Klingman D; Lin J; Pathak P; Battleman DS
Ann Pharmacother; 2009 May; 43(5):840-8. PubMed ID: 19417111
[TBL] [Abstract][Full Text] [Related]
36. Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy.
Guérin A; Lin J; Jhaveri M; Wu EQ; Yu AP; Cloutier M; Gauthier G; Alpert JS
Int J Cardiol; 2013 Jul; 167(2):564-9. PubMed ID: 22336254
[TBL] [Abstract][Full Text] [Related]
37. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause.
Scheuermeyer FX; Grafstein E; Stenstrom R; Innes G; Heslop C; MacPhee J; Pourvali R; Heilbron B; McGrath L; Christenson J
Ann Emerg Med; 2012 Dec; 60(6):755-765.e2. PubMed ID: 22738681
[TBL] [Abstract][Full Text] [Related]
38. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization.
Sarkar S; Koehler J; Crossley GH; Tang WH; Abraham WT; Warman EN; Whellan DJ
Am Heart J; 2012 Oct; 164(4):616-24. PubMed ID: 23067922
[TBL] [Abstract][Full Text] [Related]
39. Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation.
Kim MH; Lin J; Hussein M; Battleman D
Curr Med Res Opin; 2009 May; 25(5):1215-20. PubMed ID: 19327101
[TBL] [Abstract][Full Text] [Related]
40. The costs of atrial fibrillation in patients with cardiovascular comorbidities--a longitudinal analysis of German health insurance data.
Reinhold T; Lindig C; Willich SN; Brüggenjürgen B
Europace; 2011 Sep; 13(9):1275-80. PubMed ID: 21515590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
